Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA-Reference-Cited by-同舟云学术

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA

Published:2016-11-09 Issue:364 Volume:8 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Scherer Florian¹,Kurtz David M.¹²³,Newman Aaron M.¹⁴,Stehr Henning⁵,Craig Alexander F. M.¹,Esfahani Mohammad Shahrokh¹,Lovejoy Alexander F.⁴⁵⁶,Chabon Jacob J.⁴,Klass Daniel M.¹⁴⁵,Liu Chih Long¹⁴,Zhou Li⁵,Glover Cynthia¹,Visser Brendan C.⁷,Poultsides George A.⁷,Advani Ranjana H.¹,Maeda Lauren S.¹³,Gupta Neel K.¹³,Levy Ronald¹,Ohgami Robert S.⁸,Kunder Christian A.⁸,Diehn Maximilian⁴⁵⁶,Alizadeh Ash A.¹³⁴⁵

Affiliation:

1. Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

2. Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.

3. Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

4. Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.

5. Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA.

6. Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA.

7. Division of Surgical Oncology, Department of Surgery, Stanford University, Stanford, CA 94305, USA.

8. Department of Pathology, Stanford University, Stanford, CA 94305, USA.

Abstract

Circulating tumor DNA reveals patterns of clonal evolution and allows classification of tumor subtypes in lymphoma.

Funder

Damon Runyon Cancer Research Foundation

American Society of Hematology Scholar Award

V Foundation for Cancer Research Abeloff Scholar Award

German Research Foundation

National Cancer Institute

U.S. NIH Director’s New Innovator Award Program

Ludwig Institute for Cancer Research

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference82 articles.

1. The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification

2. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

3. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

4. Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin: Seeing the Forest and the Trees

5. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

Cited by 347 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas;Blood Advances;2024-02-13

2. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy;Frontiers in Oncology;2024-01-25

3. Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes;Cancer Research and Treatment;2024-01-15

4. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas;Cancers;2024-01-11

5. Exome and targeted sequencing in clinical oncology- Diffuse large B-cell lymphoma as a model;Comprehensive Precision Medicine;2024